MedTrace Logo

The ILLUMINA Study. (ILLUMINA)

NCT03510676 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-07-13

No results posted yet for this study

Summary

The aim of the prospective, multicentre, single-arm study is to assess safety and efficacy of a drug eluting stent in Nitinol alloy (NiTiDES) in term of vessel patency and composite event-free survival rate up to two years follow-up in focal/medium length lesions in patients with ischemic obstruction of superficial femoral arteries or/and proximal popliteal arteries.

Conditions

  • Peripheral Arterial Disease

Interventions

DEVICE

NiTiDES

Sponsors & Collaborators

  • CID - Carbostent & Implantable Devices

    lead INDUSTRY

Principal Investigators

  • Dierk Scheinert · Universitätsklinikum Leipzig, Germany

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-26
Primary Completion
2018-03-07
Completion
2019-03-07

Countries

  • France
  • Germany
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03510676 on ClinicalTrials.gov